Evidence map›Paper›PMID 41249141›Full record

ArticleCell death discovery2025

HMOX1 interacts with BNIP3 to modulate neuronal ferroptosis after spinal cord ischemia-reperfusion injury via a mitophagy-dependent mechanism.

Yanni Duan, Yibao Zhang, Fengguang Yang, Mingtao Zhang, Yujun Shi, Zongyan Ma, Xingxing Huang, Wen Li, Yun Lang, Xuchang Hu and 1 more

Abstract read
In one paragraph

Article in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yanni Duan *Department of Neurovascular Function Examination, The Second Hospital of Lanzhou University, Lanzhou, 730000, China.ORCID http://orcid.org/0009-0000-8783-4558
Yibao Zhang *The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730000, China.
Fengguang YangThe Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730000, China.
Mingtao ZhangThe Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730000, China.
Yujun ShiDepartment of Neurovascular Function Examination, The Second Hospital of Lanzhou University, Lanzhou, 730000, China.
Zongyan MaDepartment of Neurovascular Function Examination, The Second Hospital of Lanzhou University, Lanzhou, 730000, China.
Xingxing HuangDepartment of Neurovascular Function Examination, The Second Hospital of Lanzhou University, Lanzhou, 730000, China.
Wen LiDepartment of Neurovascular Function Examination, The Second Hospital of Lanzhou University, Lanzhou, 730000, China.
Yun LangDepartment of Neurovascular Function Examination, The Second Hospital of Lanzhou University, Lanzhou, 730000, China.
Xuchang HuThe Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730000, China.
Xuewen KangThe Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730000, China. ery_kangxw@lzu.edu.cn.ORCID http://orcid.org/0000-0002-5877-9198

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82272536
6 · The paper itself

Abstract

Spinal cord ischemia-reperfusion injury (SCIRI) is a severe secondary complication of trauma, spinal cord decompression, and thoracoabdominal aortic surgery. Ferroptosis, a regulated cell death pathway characterized by iron-dependent accumulation of lethal reactive oxygen species and lipid peroxidation, has been implicated in various pathological conditions. However, its precise role and molecular mechanisms in SCIRI remain unclear. In this study, we demonstrated that ferroptosis contributes to the pathophysiology of SCIRI. Heme oxygenase 1 (HMOX1) was upregulated in both SCIRI rats and neuronal cells subjected to hypoxia-reoxygenation. Genetic knockdown of HMOX1 in vivo and in vitro markedly attenuated neuronal ferroptosis, improving neurological function, whereas HMOX1 overexpression reproduced characteristic ferroptotic events in vitro. HMOX1 upregulation appeared to stimulate autophagic flux and induce substantial mitophagy, suggesting a potential mechanistic link between HMOX1 and ferroptosis promotion. Mitophagy reduction diminished HMOX1-mediated ferroptosis, whereas mitophagy induction acted synergistically with HMOX1. HMOX1 physically interacted with BNIP3, triggering excessive mitophagy and subsequent ferroptosis. In this study, we establish ferroptosis as a critical contributor to SCIRI pathogenesis and identify HMOX1 as a central regulator of this process. Furthermore, mitophagy-dependent ferroptosis, mediated by the HMOX1-BNIP3 axis, emerges as a promising therapeutic target for SCIRI intervention.

Identifiers

PMID41249141
PMCPMC12623955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.